This study aimed to assess the effects of GH adjuvant therapy on the cumulative live birth
rate in patients with poor embryo quality and to determine the characteristics of patients who …

Background Patients undergoing in vitro fertilisation (IVF) receive various adjuvant therapies
in order to enhance success rates, but the true benefit is actively debated. Growth hormone …

Objectives To evaluate the effectiveness of Growth hormone (GH) co-treatment during in
vitro fertilization (IVF) cycles in women of different ages who manifest unexplained poor …

Purpose No research has studied the effect of GH co-treatment in mild stimulation protocol
for poor responders. We therefore conducted this retrospective analysis to assess the …

Background Growth hormone (GH) has been proposed as an adjunct in in vitro fertilization
(IVF)/intracytoplasmic sperm injection (ICSI) cycles, especially in women with poor ovarian …

In a sequential crossover study of IVF conducted from 2002 to 2006, growth hormone (GH)
supplementation was assessed in poor-prognosis patients, categorized on the basis of past …

Growth hormone (GH) has been shown to improve implantation and live birth rates in
women of> 40 years of age treated by in vitro fertilization (IVF). This effect was initially …

Objective The aim of the study was to evaluate the use of hGH during ovarian stimulation in
bad prognosis patients in terms of oocytes retrieved, blastocyst, good quality blastocyst …

Background Many studies have demonstrated the benefits of the addition of growth hormone
(GH) to the controlled ovarian stimulation protocol in vitro fertilization (IVF) cycles in poor …

This open label randomized study aims to define the best protocol to be used with growth
hormone in poor responders, with comparison performed to delineate which protocol offers …